Skip to main content
. 2017 Sep;5(18):379. doi: 10.21037/atm.2017.07.10

Figure 2.

Figure 2

Proposed use of liquid biopsy in EGFR-mutated lung cancer. EGFR (+), positive for activating EGFR mutations; TKI, tyrosine kinase inhibitor; T790M (+), positive for EGFR T790M. EGFR, epidermal growth factor receptor.